7 results
·
26ms
·
Sources: EU EUDAMED, US FDA
UpDoc
FDA 510(k)
FDA Class 2
·Anesthesiology
EVMS (ENTERPRISE VISUAL MEDICAL SYSTEM SOFTWARE)
FDA 510(k)
FDA Class 2
·Radiology
BrightMatter Guide with Surface Trace Registration
FDA 510(k)
FDA Class 2
·Neurology
LIFELINE, AED
FDA Adverse Event
Death
·DEFIBTECH, LLC·Product code MKJ·December 5, 2008
UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM
FDA Adverse Event
Malfunction
·BECKMAN COULTER, INC.·Product code JJE·September 9, 2011
RESERVOIR 3ML
FDA Adverse Event
Malfunction
·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code FRN·July 29, 2013
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014